2022
Moving from Evidence to Implementation of Breakthrough Therapies for Diabetic Kidney Disease
Tuttle KR, Wong L, St. Peter W, Roberts G, Rangaswami J, Mottl A, Kliger A, Harris RC, Gee PO, Fowler K, Cherney D, Brosius FC, Argyropoulos C, Quaggin SE. Moving from Evidence to Implementation of Breakthrough Therapies for Diabetic Kidney Disease. Clinical Journal Of The American Society Of Nephrology 2022, 17: 1092-1103. PMID: 35649722, PMCID: PMC9269635, DOI: 10.2215/cjn.02980322.Commentaries, Editorials and LettersConceptsDiabetic kidney diseaseKidney disease careKidney diseaseHealth care systemDisease careKidney failureGlucagon-like peptide-1 receptor agonistsSodium-glucose cotransporter 2 inhibitorsPeptide-1 receptor agonistsAngiotensin-converting enzyme inhibitorBreakthrough therapiesMajor public health challengeHealth care system supportCare systemAngiotensin receptor blockersCotransporter 2 inhibitorsHalf of patientsPocket drug costsIndividual health care systemsPublic health challengeHealth care professionalsValue-based careEligible patientsMineralocorticoid antagonistsCardiovascular events
2000
Chronic renal insufficiency: Current understandings and their implications
Bolton W, Kliger A. Chronic renal insufficiency: Current understandings and their implications. American Journal Of Kidney Diseases 2000, 36: s4-s12. PMID: 11118153, DOI: 10.1053/ajkd.2000.19926.Commentaries, Editorials and LettersConceptsChronic renal insufficiencyHealthy People 2010Kidney diseaseComorbid conditionsRenal replacement therapyChronic kidney diseaseCare of patientsClear diagnostic criteriaPopulation-based surveyAvailable epidemiologic dataHealth care resourcesPractical screening testHealth care systemExpeditious referralRenal dysfunctionRenal insufficiencyUremic complicationsCreatinine levelsKidney failureReplacement therapyAppropriate referralBlack raceOptimal careSpecialty careMale gender